**3.4 Ω3-Fatty acids**

Studies have suggested that people with NAFLD can benefit from the usage of 3-fatty acids. Treatment with 3-Fatty acids was observed to ameliorate hepatic steatosis as well as the levels of AST in a meta-analysis of nine studies involving 355 individuals. Additionally, there was a tendency for the levels of ALT to rise. Only hepatic steatosis continued to improve with therapy with omega-3 fatty acids when the analysis was limited to randomized trials [21, 22].
